View Author
patient cancer imatinib expression level dicer tumor response transporter breast study rankl treatment drosha neuropathy analysis rank expression abcb 1 oncology survival breast cancer patients cml patients myeloid leukemia sample pharmacokinetic european metastasi correlation resistance table neurotoxicity therapy receptor breast cancer italy factor association alcohol consumption abcg 2 group imatinib pharmacokinetics g 2–g neurotoxicity result uptake stromal tumors regimen myeloid development outcome leukemia tissue efflux transporters stromal bone metastasis drug transporters dicer expression levels april oxaliplatin-induced population prognostic / european journal plasma microarray protein oct 1 imatinib therapy oxaliplatin mirna research alcohol signi prognosis receptor activator oxaliplatin-induced neuropathy colorectal imatinib mesylate figure consumption drosha expression levels efflux
7 Most Recent Publications
|
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients
(Article)
Vincenzi, B. Zoccoli, A. Correale, P. Riva, E. Russo, A.P. Loupakis, F. Falcone, A. Santini, D. Tonini, G. Schiavon, G. Iuliani, M. Pantano, F. Dell'Aquila, E. Ratta, R. Muda, A.O. Perrone, G. Brunelli, C. |
2013-04-01
|
|
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors
(Article)
Oudijk, L. Gaal, J. Loon, R.L.E. van O'Sullivan, M.J. Krijger, R.R. de Dinjens, W.N.M. Korpershoek, E. Nederveen, F.H. van Kelly, L. Schiavon, G. Verweij, J. Mathijssen, R.H.J. Bakker, M.A. den Oldenburg, R. |
2013-03-01
|
|
Erratum to: Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
(Article)
Vincenzi, B. Frezza, A.M. Schiavon, G. Spoto, C. Silvestris, N. Addeo, R. Catalano, V. Graziano, F. Santini, D. Tonini, G. |
2013-01-28
|
|
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
(Article)
Vincenzi, B. Frezza, A.M. Schiavon, G. Spoto, C. Addeo, R. Catalano, V. Graziano, F. Santini, D. Tonini, G. |
2012-11-30
|
|
Receptor activator of NF-kB (rank) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients
(Article)
Santini, D. Schiavon, G. La Verde, N. Caroti, C. Treilleux, I. Ruggiero, A. Perrone, G. Addeo, R. Clezardin, P. Muda, A.O. Tonini, G. Vincenzi, B. Gaeta, L. Pantano, F. Russo, A.P. Ortega, C. Porta, C. Galluzzo, S. Armento, G. |
2011-05-13
|
|
Free mobility of medical oncologists across the European Union: Still a false myth
(Article)
Schiavon, G. Zambelli, A. |
2011-03-01
|
|
Drug transporters and imatinib treatment: Implications for clinical practice
(Article)
Eechoute, K. Sparreboom, A. Burger, H. Franke, R.M. Schiavon, G. Verweij, J. Loos, W.J. Wiemer, E.A.C. Mathijssen, R.H.J. |
2011-02-01
|
